Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-13

Clinical Trial Update: A Study Comparing Degu Insulin Liraglutide Injection With Premixed Insulin on the Prognosis of Diabetes Mellitus [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is comparing Degu Insulin Liraglutide Injection with Premixed Insulin to study prognosis in Type 2 diabetes mellitus. The study is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Degu Insulin Liraglutide Injection (liraglutide-insulin combination)
  • Premixed Insulin (insulin premix)

Snippet

Sponsor: Beijing Tsinghua Chang Gung Hospital | Conditions: Type 2 Diabetic Patients | Phase 4 | Status: ENROLLING_BY_INVITATION